16 February 2021 | 07:31am
StockMarketWire.com - Disease test-kit supplier Omega Diagnostics welcomed the publication of positive research that had analysed the performance of a Covid-19 test that it is helping to produce.
A pre-print publication, funded by Public Health England, had reviewed performance of rapid antibody tests, including the AbC-19TM test being developed by the UK Rapid Test Consortium, of which Omega was a partner.
The study showed that AbC-19TM was highly accurate when tested on samples from individuals previously positive for the virus by PCR and from samples collected pre-pandemic.
All devices tested had accuracy of above 92% with the AbC-19 TM rapid test showing the highest accuracy at 97.3%.
Leading Covid antibody test developer completes major expansion in York A YORK-based company creating a rapid coronavirus antibody test has completed a major expansion of its base in the city. Abingdon Health has finished the work at its rapid test manufacturing and research facility at York Biotech Campus. The new space means that the biotechnology company now has the capacity to manufacture millions of rapid tests a month. These tests quickly detect the presence of biomarkers and pathogens within people, animals or crops.
The expansion was in response to an increase in market demand, heightened by the Covid-19 pandemic. Abingdon Health, a world-leading developer and manufacturer of high-quality rapid tests across industry sectors, including healthcare and Covid-19, is the lead in the UK Rapid Test Consortium, delivering millions of antibody rapid tests that determine if someone has Covid-19 antibodies. This is increasingly important for the international roll-out o
As Britons wait for the Covid vaccine rollout and more regions face being plunged into Tier 4, testing has become more important than ever.
Which is why MyHealthChecked, formerly known as Concepta, was a big hit with investors after it was added to the Government s approved list for private testing providers.
The AIM-listed firm will also be included on the test-to-release scheme for international travel, which can reduce the ten-day quarantine period for people who have come to the UK from a country not included in the travel corridor arrangements.
Share rise: MyHealthChecked, formerly known as Concepta, was a big hit with investors after it was added to the Government s approved list for private testing providers